comparemela.com

Latest Breaking News On - India centric epidemic preparedness - Page 1 : comparemela.com

Indigenous mRNA vaccine candidate supported by DBT gets Drug Controller nod to initiate human clinical trials

Representative Image ANI | Updated: Dec 11, 2020 21:03 IST New Delhi [India], December 11 (ANI): In a major development in the fight against COVID-19, India s first indigenous mRNA vaccine candidate has received approval from Indian Drug regulators to initiate Phase I/II human clinical trial. The novel mRNA vaccine candidate, HGCO19 has been developed by Gennova, Pune, and supported with a seed grant under the Ind-CEPI mission of the Department of Biotechnology of Union Ministry of Science and Technology. According to a release from the Ministry of Science and Technology, the mRNA vaccines do not use the conventional model to produce an immune response.

India s first indigenous mRNA vaccine candidate gets DCGI nod for human trial

New Delhi: India’s first indigenous mRNA vaccine candidate has received approval from the Drug Controller General of India to initiate Phase I/II human clinical trial, the Ministry of Earth Sciences said Friday. The novel mRNA vaccine candidate, HGCO19 has been developed by Gennova, a company based in Pune and supported with seed grant under the Ind-CEPI mission of Department of Biotechnology of Science and Technology Ministry. The mRNA vaccines do not use the conventional model to produce immune response. Instead, mRNA vaccine carries the molecular instructions to make the protein in the body through a synthetic RNA of the virus.

India s first mRNA vaccine for Covid-19 heads for human trials

India s first indigenous mRNA vaccine candidate has received approval from the Drug Controller General of India to initiate Phase I/II human clinical trial, the Ministry of Earth Sciences said on Friday. The novel mRNA vaccine candidate, HGCO19 has been developed by Gennova, a company based in Pune and supported with seed grant under the Ind-CEPI mission of Department of Biotechnology of Science and Technology Ministry. The mRNA vaccines do not use the conventional model to produce immune response. Instead, mRNA vaccine carries the molecular instructions to make the protein in the body through a synthetic RNA of the virus.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.